Opicapone
Opicapone is a potent inhibitor of catechol-O-methyltransferase (COMT). It inhibits rat peripheral COMT with ED₅₀ values below 1.4 mg/kg up to 6 h post-administration. It is approved for use as adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease.
Product Specifications
Shipping Conditions
Gel Pack
Storage Conditions
-20ºC
Shelf Life
36 months
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15373725 1 Vial
Lentiviral human ZBED8 sgRNA gene knockout kit - Lentiviral human ZBED8 sgRNA gene knockout kit (25)
Sign In for Pricing
View Details 
